Alphatec Holdings, INC 8-K filings

Alphatec Holdings announced the approval of its 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan by stockholders at its annual meeting.

Alphatec Holdings announced a new $300 million senior secured credit agreement, including a $175 million term loan and a $125 million revolving credit facility, to refinance existing debt and support future growth.

Alphatec Holdings, Inc. announced the retirement of Director Ward W. Woods, effective February 27, 2026, with his remaining unvested restricted stock units immediately vesting.

Alphatec Holdings, Inc. announced robust full-year 2025 financial results, including 25% revenue growth and a pivotal shift to positive free cash flow, alongside an optimistic 2026 outlook.

Alphatec Holdings, Inc. announced preliminary unaudited financial results for 2025, showing significant revenue growth, and provided a positive financial outlook for 2026, alongside acquiring exclusive distribution rights for a next-generation biologic.

Alphatec Holdings, Inc. announced with deep sadness the passing of Jeffrey P. Rydin, a long-serving and influential member of its Board of Directors.

Alphatec Holdings, Inc. announced strong third-quarter 2025 financial results, with total revenue growing 30% and a significant increase in full-year revenue and profitability guidance.

Alphatec Holdings, Inc. reported robust second-quarter 2025 financial results, showcasing significant revenue growth and a shift to non-GAAP net income profitability, prompting an increase in its full-year 2025 guidance.

Alphatec Holdings, Inc. announced that its stockholders approved an amendment to increase the total authorized shares to 420 million and common stock to 400 million, alongside an expansion of its equity incentive plan and the re-election of its board of directors.

Alphatec Holdings announces positive Q1 2025 financial results, including a 22% increase in total revenue, and raises its full-year revenue and profitability guidance.

Alphatec Holdings introduces a salary conversion plan where executives, including Named Executive Officers (NEOs), will receive restricted stock units (RSUs) in lieu of a portion of their cash salaries.

Alphatec Holdings finalized the repurchase of $253.0 million of its 2026 convertible notes and updated the share cap related to the 2030 convertible notes.

Alphatec Holdings completed the issuance of $405 million in convertible senior notes due 2030 and repurchased $253 million of its 2026 notes.

Alphatec Holdings announces the pricing of a $350 million convertible senior notes offering due in 2030, increased from the initially planned $300 million.

Alphatec Holdings plans to offer $300 million in convertible senior notes due 2030 in a private offering to qualified institutional buyers.

Alphatec Holdings announces a 27% increase in full-year 2024 revenue to $612 million and forecasts approximately $732 million in revenue for 2025.

Alphatec Holdings reports a 27% revenue increase for 2024 and projects positive free cash flow for 2025.

Alphatec Holdings, Inc. announced robust third-quarter 2024 financial results, highlighted by a 30% surgical revenue growth and a 27% total revenue increase, leading to an improved full-year guidance.

Alphatec Holdings announced a 25% increase in total revenue for the second quarter of 2024, driven by a 27% growth in surgical revenue, and raised its full-year revenue and profitability guidance.

Alphatec Holdings held its annual meeting, elected directors, ratified its auditor, and approved executive compensation, while also finalizing a vesting agreement with a departing director.

Alphatec Holdings reported a strong first quarter in 2024 with a 27% revenue increase and raised its full-year revenue and adjusted EBITDA guidance.

Alphatec Holdings presented its 2024 Investor Day presentation on March 19, 2024, in New York City, which was also broadcast via webcast.

Alphatec Holdings announced a 37% increase in full-year 2023 revenue to $482 million and projects continued growth with a revenue target of $595 million for 2024.